Brief: Panacea Biotec March-Quarter Consol Loss Narrows
29/06/2020 14:32
June 29 (Reuters) - Panacea Biotec Ltd PNCA.NS :
* MARCH-QUARTER CONSOL NET LOSS 13.1 MILLION RUPEES VERSUS
LOSS
64.3 MILLION RUPEES
* MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 1.25 BILLION
RUPEES
VERSUS 1.23 BILLION RUPEES
Source text for Eikon: ID:
Further company coverage: PNCA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panacea Biotec
See all newsBrief: Panacea Biotec Receives Letter Of Award For BOPV Supply Worth $8.205 Million
Brief: Panacea Biotec Unit Gets Show Cause Notice Alleging Total Tax Liability Of 40.6 Million Rupees
Brief: Panacea Biotec Files Appeal Against Fourth Industrial Tribunal (Mohali) Award
India's Panacea Biotec rises to record high on EU-backed dengue vaccine project
India Stocks: Indian shares rise as banks gain on RBI forex swap facility